Aethlon Medical (Nasdaq: AEMD) Studies Constant Directional Modifications in Second Cohort of Australian Hemopurifier Oncology Trial
Second cohort findings in step with beforehand reported observations; an unbiased statistical evaluation is deliberate following ...
Read more
